ST Pharm said Tuesday that it has signed a consultative research agreement with Pohang University of Science and Technology (POSTECH) to develop ways to mass-manufacture lipid nanoparticle (LNP)-based capsulized mRNA vaccines.Under the accord, researchers of POSTECH's Center for Intelligent Micropro
Ipsen’s next-generation tyrosine kinase inhibitor (TKI) Cabometyx (ingredient: cabozantinib) in combination with an immune checkpoint inhibitor failed to provide longer overall survival (OS), compared to Bayer’s Nexavar (sorafenib) in the first-line treatment of hepatocellular carcinoma (HCC).On Mon
Huons Global said that a consortium led by the company would manufacture Sputnik Light, a single-dose version of Russia’s Covid-19 vaccine Sputnik V.The Huons Global Consortium recently completed final discussions with the Russian Direct Investment Fund (RDIF) on the local production of Sputnik Ligh
JW Pharmaceutical said Monday that it has acquired exclusive rights of fostamatinib, a treatment for thrombocytopenia, from Japan’s Kissei Pharmaceutical to develop and market the drug in Korea, strengthening its hemato-oncology portfolio.The company also plans to receive orphan drug status from the
Novo Nordisk has diversified the product line of semaglutide to fight against Lilly’s GIP/GLP-1 dual agonist tirzepatide that has a strong hypoglycemic effect in the diabetes treatment market.After releasing the oral semaglutide (brand name: Rybelsus), Novo Nordisk recently tested a high-dose semagl
Korean companies donated large sums of money to the Vietnamese government's request for contributing to funds to purchase Covid-19 vaccines to inoculate its citizens.Samsung Electronics was the first Korean company to make a donation to Vietnam. According to the Vietnamese government and local indus
Bridge Biotherapeutics said Monday that the U.S. Food and Drug Administration (FDA) has requested the company to provide results proving the safety of its idiopathic pulmonary fibrosis drug candidate BBT-877 to conduct phase 2 clinical trials.The FDA recommended that the company submit further resul
inno.N said it has licensed out injection technology for its gastroesophageal reflux disease (GERD) therapy, K-CAB, to Shandong Luoxin Pharmaceutical Group, a Chinese pharmaceutical company.Under the accord, inno.N will receive royalties from Luoxin after its launch in China, and Luoxin will have ex
Researchers at the Korea Institute of Science and Technology (KIST) and Korea Research Institute of Bioscience & Biotechnology (KRIBB) have discovered the principle of decomposing tau protein, pointed out as a strong cause of dementia, through autophagy.“According to an analysis of the current statu
Genexine said Friday that it had applied for a patent for a plasmid DNA-based self-amplifying mRNA hybrid vaccine technology developed jointly with its local partner, SL Vaccigen.The technology will be applied to the future development of various vaccines, including the Covid-19 jab, the company sai
Medytox said Friday that it has obtained regulatory approval for marketing its botulinum toxin (BTX) Meditoxin in Taiwan and plans to expand its business targets to ethnic Chinese markets in Southeast Asian countries. The Taiwan Food and Drug Administration granted rights to Medytox to sell 100 and
Hanmi Pharmaceutical said Thursday that its non-alcoholic steatohepatitis (NASH) drug candidate, LAPS Triple Agonist (HM15211), showed potential for treating other rare liver diseases.The company presented three studies of its triple agonist’s therapeutic effect in NASH patients and efficacy and mec
Medytox said Thursday the Ministry of Food and Drug Safety has approved its investigational new drug (IND) application to conduct the phase 3 clinical trial of MBA-P01, a next-generation botulinum toxin (BTX) formulation.Medytox plans to conduct a phase 3 clinical trial on 318 patients who need mode
Daewoong Pharmaceutical said it would export its gastroesophageal reflux treatment, Fexuprazan, to four more Latin American countries through a contract with Biopas, a Columbia-based pharmaceutical company.The other three importers under the 34 billion won ($3 million) export contract are Chile, Ecu
Medytox said it has reached an agreement with AEON Biopharma, one of Daewoong Pharmaceutical's U.S. partners for its botulinum toxin (BTX).AEON Biopharma is an exclusive partner with the right to license, import, and sell Daewoong's BTX Nabota, also known as ABP-450, for therapeutic purposes in the
Pfizer Korea has interrupted the distribution of its anti-nicotine therapy Champix to dispel concerns over the treatment's nitrosamine impurities, a possible carcinogen substance.According to the industry insiders on Wednesday, Pfizer Korea recently sent an official letter to local drug distributors
Yuhan Corp.’s Leclaza (ingredient: lazertinib), a third-generation treatment for EGFR-mutated non-small cell lung cancer (NSCLC), has won the health insurance benefits in just six months of obtaining the marketing license.However, AstraZeneca’s Tagrisso (osimertinib), which was developed before Lecl
MSD Korea said Tuesday that it has confirmed the efficacy of PD-1 inhibitor Keytruda (ingredient: pembrolizumab) in treating Bacillus Calmette-Guerin (BCG)-unresponsive and non-muscle-invasive bladder cancer patients regardless of cystectomy or presence of papillomas.In phase 2 KEYNOTE-057 trial tha
Some Korean Covid-19 vaccine developers are expected to face difficulty in conducting late-stage clinical trials on time, raising concerns that the nation might not be able to secure “vaccine sovereignty.”The delay will result from challenges such as high costs and additional verification of candida
Korea United Pharmaceuticals said that it recently signed a contract with Medimex, a drug procurement company designated by the Mexican government, to distribute and sell 16 types of anticancer drugs in Mexico."The contract size is $14.04 million in the first year, and the company plans to exports c